Cargando…

iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium

We investigate the effects of myocardial transplantation of human induced pluripotent stem cell (iPSC)‐derived progenitors and cardiomyocytes into acutely infarcted myocardium in severe combined immune deficiency mice. A total of 2 × 10(5) progenitors, cardiomyocytes or cell‐free saline were injecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ja, KP Myu Mia, Miao, Qingfeng, Zhen Tee, Nicole Gui, Lim, Sze Yun, Nandihalli, Manasi, J.A. Ramachandra, Chrishan, Mehta, Ashish, Shim, Winston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727567/
https://www.ncbi.nlm.nih.gov/pubmed/26612359
http://dx.doi.org/10.1111/jcmm.12725
_version_ 1782411984144171008
author Ja, KP Myu Mia
Miao, Qingfeng
Zhen Tee, Nicole Gui
Lim, Sze Yun
Nandihalli, Manasi
J.A. Ramachandra, Chrishan
Mehta, Ashish
Shim, Winston
author_facet Ja, KP Myu Mia
Miao, Qingfeng
Zhen Tee, Nicole Gui
Lim, Sze Yun
Nandihalli, Manasi
J.A. Ramachandra, Chrishan
Mehta, Ashish
Shim, Winston
author_sort Ja, KP Myu Mia
collection PubMed
description We investigate the effects of myocardial transplantation of human induced pluripotent stem cell (iPSC)‐derived progenitors and cardiomyocytes into acutely infarcted myocardium in severe combined immune deficiency mice. A total of 2 × 10(5) progenitors, cardiomyocytes or cell‐free saline were injected into peri‐infarcted anterior free wall. Sham‐operated animals received no injection. Myocardial function was assessed at 2‐week and 4‐week post‐infarction by using echocardiography and pressure‐volume catheterization. Early myocardial remodelling was observed at 2‐week with echocardiography derived stroke volume (SV) in saline (20.45 ± 7.36 μl, P < 0.05) and cardiomyocyte (19.52 ± 3.97 μl, P < 0.05) groups, but not in progenitor group (25.65 ± 3.61 μl), significantly deteriorated as compared to sham control group (28.41 ± 4.41 μl). Consistently, pressure–volume haemodynamic measurements showed worsening chamber dilation in saline (EDV: 23.24 ± 5.01 μl, P < 0.05; ESV: 17.08 ± 5.82 μl, P < 0.05) and cardiomyocyte (EDV: 26.45 ± 5.69 μl, P < 0.05; ESV: 18.03 ± 6.58 μl, P < 0.05) groups by 4‐week post‐infarction as compared to control (EDV: 15.26 ± 2.96 μl; ESV: 8.41 ± 2.94 μl). In contrast, cardiac progenitors (EDV: 20.09 ± 7.76 μl; ESV: 13.98 ± 6.74 μl) persistently protected chamber geometry against negative cardiac remodelling. Similarly, as compared to sham control (54.64 ± 11.37%), LV ejection fraction was preserved in progenitor group from 2‐(38.68 ± 7.34%) to 4‐week (39.56 ± 13.26%) while cardiomyocyte (36.52 ± 11.39%, P < 0.05) and saline (35.34 ± 11.86%, P < 0.05) groups deteriorated early at 2‐week. Improvements of myocardial function in the progenitor group corresponded to increased vascularization (16.12 ± 1.49/mm(2) to 25.48 ± 2.08/mm(2) myocardial tissue, P < 0.05) and coincided with augmented networking of cardiac telocytes in the interstitial space of infarcted zone.
format Online
Article
Text
id pubmed-4727567
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-47275672016-02-03 iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium Ja, KP Myu Mia Miao, Qingfeng Zhen Tee, Nicole Gui Lim, Sze Yun Nandihalli, Manasi J.A. Ramachandra, Chrishan Mehta, Ashish Shim, Winston J Cell Mol Med Original Articles We investigate the effects of myocardial transplantation of human induced pluripotent stem cell (iPSC)‐derived progenitors and cardiomyocytes into acutely infarcted myocardium in severe combined immune deficiency mice. A total of 2 × 10(5) progenitors, cardiomyocytes or cell‐free saline were injected into peri‐infarcted anterior free wall. Sham‐operated animals received no injection. Myocardial function was assessed at 2‐week and 4‐week post‐infarction by using echocardiography and pressure‐volume catheterization. Early myocardial remodelling was observed at 2‐week with echocardiography derived stroke volume (SV) in saline (20.45 ± 7.36 μl, P < 0.05) and cardiomyocyte (19.52 ± 3.97 μl, P < 0.05) groups, but not in progenitor group (25.65 ± 3.61 μl), significantly deteriorated as compared to sham control group (28.41 ± 4.41 μl). Consistently, pressure–volume haemodynamic measurements showed worsening chamber dilation in saline (EDV: 23.24 ± 5.01 μl, P < 0.05; ESV: 17.08 ± 5.82 μl, P < 0.05) and cardiomyocyte (EDV: 26.45 ± 5.69 μl, P < 0.05; ESV: 18.03 ± 6.58 μl, P < 0.05) groups by 4‐week post‐infarction as compared to control (EDV: 15.26 ± 2.96 μl; ESV: 8.41 ± 2.94 μl). In contrast, cardiac progenitors (EDV: 20.09 ± 7.76 μl; ESV: 13.98 ± 6.74 μl) persistently protected chamber geometry against negative cardiac remodelling. Similarly, as compared to sham control (54.64 ± 11.37%), LV ejection fraction was preserved in progenitor group from 2‐(38.68 ± 7.34%) to 4‐week (39.56 ± 13.26%) while cardiomyocyte (36.52 ± 11.39%, P < 0.05) and saline (35.34 ± 11.86%, P < 0.05) groups deteriorated early at 2‐week. Improvements of myocardial function in the progenitor group corresponded to increased vascularization (16.12 ± 1.49/mm(2) to 25.48 ± 2.08/mm(2) myocardial tissue, P < 0.05) and coincided with augmented networking of cardiac telocytes in the interstitial space of infarcted zone. John Wiley and Sons Inc. 2015-11-27 2016-02 /pmc/articles/PMC4727567/ /pubmed/26612359 http://dx.doi.org/10.1111/jcmm.12725 Text en © 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Ja, KP Myu Mia
Miao, Qingfeng
Zhen Tee, Nicole Gui
Lim, Sze Yun
Nandihalli, Manasi
J.A. Ramachandra, Chrishan
Mehta, Ashish
Shim, Winston
iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium
title iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium
title_full iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium
title_fullStr iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium
title_full_unstemmed iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium
title_short iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium
title_sort ipsc‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727567/
https://www.ncbi.nlm.nih.gov/pubmed/26612359
http://dx.doi.org/10.1111/jcmm.12725
work_keys_str_mv AT jakpmyumia ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium
AT miaoqingfeng ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium
AT zhenteenicolegui ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium
AT limszeyun ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium
AT nandihallimanasi ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium
AT jaramachandrachrishan ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium
AT mehtaashish ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium
AT shimwinston ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium